Venture • Life Science

General Atlantic Invests In Pharvaris

On November 18, 2020, growth capital firm General Atlantic invested in life science company Pharvaris

Investment Context

This is General Atlantic’s 11th transaction in the Life Science sector.
This is General Atlantic’s 4th transaction in the Netherlands.

Investment Fate

Pharvaris went public in 2021.

Explore All 557 Venture Life Science Deals - Search the Database Free

Investment Summary
Date	November 18, 2020
Target	Pharvaris
Sector	Life Science
Investor(s)	General Atlantic
Deal Type	Venture

Target Company

Pharvaris

Leiden, Netherlands

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition. Pharvaris was founded in 2015 and is based in Leiden, Netherlands.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

General Atlantic

Investor Investor

Category	Growth Capital Firm
Founded	1980
PE ASSETS	105.0B USD
Size	Mega
Type	Sector Agnostic

DESCRIPTION

General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.

Deal Context for Investor	#
Overall	260 of 365
Sector: Life Science	11 of 20
Type: Venture	59 of 98
Country: Netherlands	4 of 8
Year: 2020	25 of 29

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2020-11-06	Gen II Fund Services New York, New York, United States Gen II Fund Services is a fund administration provider focused entirely on serving the alternative asset management space, including private equity, real estate and credit funds. Gen II Fund Services was founded in 2009 and is based in New York, New York.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2020-11-06

Gen II Fund Services

New York, New York, United States

Gen II Fund Services is a fund administration provider focused entirely on serving the alternative asset management space, including private equity, real estate and credit funds. Gen II Fund Services was founded in 2009 and is based in New York, New York.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2020-12-04	Zimmermann Rosebery, Australia Zimmermann is a global luxury fashion brand that designs and sells iconic Ready-To-Wear and Swim & Resort collections through its online platform and own retail stores, as well as select department stores, boutiques, and online fashion retailers. Zimmermann was founded in 1991 and is based in Rosebery, Australia.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2020-12-04

Zimmermann

Rosebery, Australia

Zimmermann is a global luxury fashion brand that designs and sells iconic Ready-To-Wear and Swim & Resort collections through its online platform and own retail stores, as well as select department stores, boutiques, and online fashion retailers. Zimmermann was founded in 1991 and is based in Rosebery, Australia.

Sell

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - Netherlands M&A - 2020 M&A